144 related articles for article (PubMed ID: 8723318)
1. Comparative interaction kinetics of two recombinant Fabs and of the corresponding antibodies directed to the coat protein of tobacco mosaic virus.
Chatellier J; Rauffer-Bruyère N; Van Regenmortel MH; Altschuh D; Weiss E
J Mol Recognit; 1996; 9(1):39-51. PubMed ID: 8723318
[TBL] [Abstract][Full Text] [Related]
2. Cooperative effects of mutations in a recombinant Fab on the kinetics of antigen binding.
Rauffer-Bruyre N; Chatellier J; Weiss E; Van Regenmortel MH; Altschuh D
Mol Immunol; 1997 Feb; 34(2):165-73. PubMed ID: 9188849
[TBL] [Abstract][Full Text] [Related]
3. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
4. Neutralisation and binding of VHS virus by monovalent antibody fragments.
Cupit PM; Lorenzen N; Strachan G; Kemp GJ; Secombes CJ; Cunningham C
Virus Res; 2001 Dec; 81(1-2):47-56. PubMed ID: 11682124
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the effect on Fab binding of identical substitutions in a peptide and its parent protein.
Choulier L; Rauffer-Bruyère N; Ben Khalifa M; Martin F; Vernet T; Altschuh D
Biochemistry; 1999 Mar; 38(12):3530-7. PubMed ID: 10090739
[TBL] [Abstract][Full Text] [Related]
6. Bacterially expressed Fabs of monoclonal antibodies neutralizing tumour necrosis factor alpha in vitro retain full binding and biological activity.
Orfanoudakis G; Karim B; Bourel D; Weiss E
Mol Immunol; 1993 Nov; 30(16):1519-28. PubMed ID: 8232337
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding.
Borrebaeck CA; Malmborg AC; Furebring C; Michaelsson A; Ward S; Danielsson L; Ohlin M
Biotechnology (N Y); 1992 Jun; 10(6):697-8. PubMed ID: 1368889
[TBL] [Abstract][Full Text] [Related]
8. VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates.
Hugo N; Weidenhaupt M; Beukes M; Xu B; Janson JC; Vernet T; Altschuh D
Protein Eng; 2003 May; 16(5):381-6. PubMed ID: 12826730
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
Wu SC; Lin YJ; Chou JW; Lin CW
Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
[TBL] [Abstract][Full Text] [Related]
10. Rapid two-step purification of a recombinant mouse Fab fragment expressed in Escherichia coli.
Wlad H; Ballagi A; Bouakaz L; Gu Z; Janson JC
Protein Expr Purif; 2001 Jul; 22(2):325-9. PubMed ID: 11437609
[TBL] [Abstract][Full Text] [Related]
11. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
[TBL] [Abstract][Full Text] [Related]
12. Functional mapping of conserved, surface-exposed charges of antibody variable domains.
Weidenhaupt M; Khalifa MB; Hugo N; Choulier L; Altschuh D; Vernet T
J Mol Recognit; 2002; 15(2):94-103. PubMed ID: 11954054
[TBL] [Abstract][Full Text] [Related]
13. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
[TBL] [Abstract][Full Text] [Related]
14. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.
Deng SJ; MacKenzie CR; Sadowska J; Michniewicz J; Young NM; Bundle DR; Narang SA
J Biol Chem; 1994 Apr; 269(13):9533-8. PubMed ID: 8144539
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
16. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
17. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
Schofield DJ; Glamann J; Emerson SU; Purcell RH
J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
[TBL] [Abstract][Full Text] [Related]
18. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus.
Pizarro JC; Vulliez-le Normand B; Riottot MM; Budkowska A; Bentley GA
FEBS Lett; 2001 Dec; 509(3):463-8. PubMed ID: 11749974
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing human Fab fragments against measles virus recovered by phage display.
de Carvalho Nicacio C; Williamson RA; Parren PW; Lundkvist A; Burton DR; Björling E
J Virol; 2002 Jan; 76(1):251-8. PubMed ID: 11739690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
